Published July 5, 2026
After Eleven Straight Years of Growth, the Industry Finally Hit Reverse
It finally happened. For the first time since legal recreational markets launched in 2014, U.S. cannabis sales declined year-over-year.
National retail revenue fell to roughly $29.1 billion in 2025, down from $30.1 billion the year before, according to the U.S. Cannabis Jobs Report from Vangst and Whitney Economics. A separate analysis from Whitney Economics and First Citizens Bank pegs the range at $28.6 to $29.6 billion. Either way, the streak is over. Twenty-three states posted declines. Industry jobs slipped 2.7% to 412,500.
A down year sounds like bad news, and for plenty of operators it was. But dig into the data and a more interesting story emerges — one about an industry growing up, not falling apart.
The Decline Isn’t About Demand. It’s About Price.
Here’s the number that reframes everything: Americans didn’t buy less cannabis in 2025. Unit volumes stayed stable or grew. Checkout data shows shoppers put the same number of items in their baskets — or slightly more — while paying the same or less for them.
What collapsed was price. And price collapsed because of oversupply on a massive scale. Whitney Economics estimates legal cultivation capacity at roughly 73 million pounds per year. Total demand — regulated and unregulated combined — sits around 50 million pounds. That’s a staggering gap, and it won’t close quickly.
The report authors summed up the chain reaction bluntly: oversupply leads to price compression, price compression crushes margins, and crushed margins push some activity back into unregulated channels. Great news if you’re a consumer. Brutal if you’re an operator absorbing rising costs for fuel, utilities, and labor while your product sells for less every quarter.
The profitability numbers show the squeeze in stark terms. Only about a quarter of cannabis operators are profitable after taxes, compared to roughly 65% of American small businesses overall. Another 40% are merely breaking even.
A Tale of Two Markets
Zoom in state by state and 2025 splits into two completely different industries.
The mature markets contracted. California remained the country’s largest market at nearly $4 billion, but sales fell 7% as 3,600-plus dispensaries fought over a consumer base that stopped growing. Michigan dropped 4% under similar pressure. Illinois had the roughest ride of all, sliding from $2 billion to roughly $1.7 billion — a decline the analysts attribute largely to high taxes pushing shoppers across the border into Michigan and Missouri.
The young markets boomed. Ohio grew regulated sales by more than $400 million — a 61.6% jump — after launching adult-use and pulling back demand that had been leaking to Michigan. New York nearly doubled its revenue to $1.6 billion as its licensed retail base expanded from 261 stores to 519 and enforcement squeezed the illicit shops. New York also added over 16,000 cannabis jobs, a 129% increase that made it the third-largest cannabis employer in the country practically overnight.
Same country, same year, same plant. The difference is market age. That’s not an industry in crisis — that’s an industry with a life cycle.
The Elephant Still in the Room: The Illicit Market
One statistic looms over all the others. Legal sales capture only about 30% of total U.S. cannabis demand. Roughly three-quarters of consumption still flows through unregulated channels, putting the combined legal-and-illegal market somewhere near $100 billion.
That’s the real growth frontier. The legal industry’s problem isn’t that Americans stopped wanting cannabis — 64 million used it in the past year, the highest ever recorded. The problem is that the legal system, with its tax burdens and compliance costs, keeps losing on price to a competitor that pays neither.
Every policy debate in the industry — taxes, licensing, enforcement, interstate commerce — is ultimately about moving some slice of that 70% into regulated stores.
Why Operators Are Weirdly Optimistic Anyway
Given all that, the outlook numbers might surprise you. Nearly 87% of surveyed operators expect revenue growth in 2026, up sharply from the 66% who actually saw growth in 2025. Forecasts call for a rebound to around $30.5 billion this year.
The optimism has a specific source: Washington, D.C. The rescheduling process now underway — with medical cannabis already moved to Schedule III in April and the DEA hearing on full rescheduling wrapping up this month — carries a massive financial prize. If marijuana lands in Schedule III, the crushing 280E tax provision stops applying, and suddenly cannabis businesses can deduct ordinary expenses like every other company in America. For an industry where three-quarters of operators can’t turn an after-tax profit, that’s not a tweak. That’s a lifeline.
Chief economist Beau Whitney has noted the industry could eventually support as many as 1.6 million workers under full federal reform — roughly four times today’s workforce.
The Takeaway: The Gold Rush Is Over. The Business Has Begun.
The first down year on record isn’t the end of the cannabis story — it’s the end of a chapter. The land-grab era, where growth papered over thin operations and bad unit economics, is finished. What’s replacing it looks like every other maturing consumer industry: consolidation, price discipline, regional divergence, and a widening gap between operators who run tight businesses and those who rode the wave.
The winners of 2026 won’t be the companies that expanded fastest. They’ll be the ones that survived 2025 with their margins intact — positioned for the moment federal reform finally changes the math.
The gold rush is over. The business has begun.
Follow the Money
From market data and M&A moves to banking reform and tax policy, the business side of cannabis is changing faster than ever. We break down what it means for operators, investors, and the industry’s future.
👉 Visit our Cannabis Business hub for the latest industry news, market analysis, and in-depth coverage from Marijuana.net.
Sources: